日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dual-modality CAD for breast cancer screening: dealing with discordant diagnosis between mammography and tomography

双模态计算机辅助诊断在乳腺癌筛查中的应用：处理乳腺X线摄影和断层摄影诊断结果不一致的问题

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1737940
Beaumont, Hubert; Iannessi, Antoine; Louis, Thomas; Pacile, Serena; Fillard, Pierre
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Radiomics-Based Prediction of Treatment Response to TRuC-T Cell Therapy in Patients with Mesothelioma: A Pilot Study

基于放射组学的间皮瘤患者TRuC-T细胞疗法疗效预测：一项初步研究

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17030463
Beaumont, Hubert; Iannessi, Antoine; Thinnes, Alexandre; Jacques, Sebastien; Quintás-Cardama, Alfonso
免疫/内分泌
细胞生物学
T细胞
T细胞
发表日期：2025
文献求助 收藏

Assessing immunotherapy response: going beyond RECIST by integrating early tumor growth kinetics

评估免疫疗法反应：超越RECIST标准，整合早期肿瘤生长动力学

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1470555
Felfli, Mehdi; Thinnes, Alexandre; Jacques, Sebastien; Liu, Yan; Iannessi, Antoine
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏

RECIST 1.1 assessments variability: a systematic pictorial review of blinded double reads

RECIST 1.1 评估变异性：盲法双读的系统性图解回顾

期刊:Insights into Imaging
影响因子:4.5
doi:10.1186/s13244-024-01774-w
Iannessi, Antoine; Beaumont, Hubert; Ojango, Christine; Bertrand, Anne-Sophie; Liu, Yan
发表日期：2024
文献求助 收藏

The ins and outs of errors in oncology imaging: the DAC framework for radiologists

肿瘤影像学误差的来龙去脉：放射科医生的 DAC 框架

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1402838
Iannessi, Antoine; Beaumont, Hubert; Aguillera, Carlos; Nicol, Francois; Bertrand, Anne-Sophie
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Systematic Review, Meta-Analysis and Radiomics Quality Score Assessment of CT Radiomics-Based Models Predicting Tumor EGFR Mutation Status in Patients with Non-Small-Cell Lung Cancer

对基于CT放射组学的模型预测非小细胞肺癌患者肿瘤EGFR突变状态进行系统评价、荟萃分析和放射组学质量评分评估

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms241411433
Felfli, Mehdi; Liu, Yan; Zerka, Fadila; Voyton, Charles; Thinnes, Alexandre; Jacques, Sebastien; Iannessi, Antoine; Bodard, Sylvain
EGFR
细胞生物学
肿瘤
EGF
肿瘤免疫
肺癌
发表日期：2023
文献求助 收藏

Breaking down the RECIST 1.1 double read variability in lung trials: What do baseline assessments tell us?

分析肺癌试验中 RECIST 1.1 双重读片变异性：基线评估告诉我们什么？

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.988784
Iannessi, Antoine; Beaumont, Hubert
肺癌
肿瘤免疫
肿瘤
发表日期：2023
文献求助 收藏

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

我们能否预测双重阅片临床试验中RECIST 1.1评价结果的不一致？

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1239570
Beaumont, Hubert; Iannessi, Antoine
发表日期：2023
文献求助 收藏

Differences in sensitivity to new therapies between primary and metastatic breast cancer: A need to stratify the tumor response?

原发性乳腺癌和转移性乳腺癌对新疗法的敏感性存在差异：是否需要对肿瘤反应进行分层？

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.5236
Beaumont, Hubert; Faye, Nathalie; Iannessi, Antoine; Chamorey, Emmanuel; Klifa, Catherine; Hsieh, Chih-Yi
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?

RECIST 1.1 和病灶选择：如何处理基线时的模糊性？

期刊:Insights into Imaging
影响因子:4.5
doi:10.1186/s13244-021-00976-w
Iannessi, Antoine; Beaumont, Hubert; Liu, Yan; Bertrand, Anne-Sophie
发表日期：2021
文献求助 收藏